FindTrial
Sign In

Impact of Virtual Reality Headset for Tobacco Cessation among Diabetes

Impact of Virtual Reality headset-assisted novel VITAL-D health program on Tobacco Cessation among tobacco users with Type 2 Diabetes mellitus: A Randomized Controlled study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096238
Enrollment
104
Registered
2025-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Virtual Reality Headset Assisted Tobacco Cessation Counselling: Virtual Reality Headset Assisted Tobacco Cessation Counselling will be provided to Type 2 Diabetic Patients who are using

Sponsors

Pallavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. More than 18 years of age b. Giving informed consent and willingness to participate c. Using tobacco in smoke or smokeless form (ST/SLT) d. Having a confirmatory diagnosis of T2DM and receiving routine medical treatment for the condition.

Exclusion criteria

Exclusion criteria: a. Having any severe/debilitating systemic co-morbidity b. Receiving any treatment for tobacco cessation within last six months c. Not being able to attend all treatment session.

Design outcomes

Primary

MeasureTime frame
Tobacco Abstinence among Type 2 Diabetic Tobacco UsersTimepoint: At Baseline and after the second and third months of follow-up—

Secondary

MeasureTime frame
• Improvement in OHRQoL in tobacco users with T2DM following the VRH assisted comprehensive health program. • Improvement in glycemic control in tobacco users with T2DM as measured by fasting and postprandial blood glucose level. Timepoint: Baseline and 6th Month—

Countries

India

Contacts

Public ContactVinay Kumar Gupta

Faculty of Dental Sciences King George Medical University

vinaykumargupta@kgmcindia.edu9794153902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026